An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice

Research output: Contribution to journalLetterResearchpeer-review

Standard

An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice. / van Oosten, Linda; Yan, Kexin; Rawle, Daniel J.; Le, Thuy T.; Altenburg, Jort J.; Fougeroux, Cyrielle; Goksøyr, Louise; de Jongh, Willem Adriaan; Nielsen, Morten A.; Sander, Adam F.; Pijlman, Gorben P.; Suhrbier, Andreas.

In: Journal of Virology, Vol. 96, No. 14, 00844-22, 2022.

Research output: Contribution to journalLetterResearchpeer-review

Harvard

van Oosten, L, Yan, K, Rawle, DJ, Le, TT, Altenburg, JJ, Fougeroux, C, Goksøyr, L, de Jongh, WA, Nielsen, MA, Sander, AF, Pijlman, GP & Suhrbier, A 2022, 'An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice', Journal of Virology, vol. 96, no. 14, 00844-22. https://doi.org/10.1128/jvi.00844-22

APA

van Oosten, L., Yan, K., Rawle, D. J., Le, T. T., Altenburg, J. J., Fougeroux, C., Goksøyr, L., de Jongh, W. A., Nielsen, M. A., Sander, A. F., Pijlman, G. P., & Suhrbier, A. (2022). An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice. Journal of Virology, 96(14), [00844-22]. https://doi.org/10.1128/jvi.00844-22

Vancouver

van Oosten L, Yan K, Rawle DJ, Le TT, Altenburg JJ, Fougeroux C et al. An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice. Journal of Virology. 2022;96(14). 00844-22. https://doi.org/10.1128/jvi.00844-22

Author

van Oosten, Linda ; Yan, Kexin ; Rawle, Daniel J. ; Le, Thuy T. ; Altenburg, Jort J. ; Fougeroux, Cyrielle ; Goksøyr, Louise ; de Jongh, Willem Adriaan ; Nielsen, Morten A. ; Sander, Adam F. ; Pijlman, Gorben P. ; Suhrbier, Andreas. / An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice. In: Journal of Virology. 2022 ; Vol. 96, No. 14.

Bibtex

@article{8968e03972394f8da9c4ade811df97b7,
title = "An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice",
keywords = "K18-hACE2, nanoparticle vaccine, SARS-CoV-2",
author = "{van Oosten}, Linda and Kexin Yan and Rawle, {Daniel J.} and Le, {Thuy T.} and Altenburg, {Jort J.} and Cyrielle Fougeroux and Louise Goks{\o}yr and {de Jongh}, {Willem Adriaan} and Nielsen, {Morten A.} and Sander, {Adam F.} and Pijlman, {Gorben P.} and Andreas Suhrbier",
note = "Funding Information: This research was funded through European Union{\textquoteright}s Horizon 2020 research and innovation program (grant agreement no. 101003608) and conducted in the H2020 Prevent-nCoV consortium. A.S. holds an Investigator grant from the National Health and Medical Research Council of Australia (APP1173880).",
year = "2022",
doi = "10.1128/jvi.00844-22",
language = "English",
volume = "96",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "14",

}

RIS

TY - JOUR

T1 - An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice

AU - van Oosten, Linda

AU - Yan, Kexin

AU - Rawle, Daniel J.

AU - Le, Thuy T.

AU - Altenburg, Jort J.

AU - Fougeroux, Cyrielle

AU - Goksøyr, Louise

AU - de Jongh, Willem Adriaan

AU - Nielsen, Morten A.

AU - Sander, Adam F.

AU - Pijlman, Gorben P.

AU - Suhrbier, Andreas

N1 - Funding Information: This research was funded through European Union’s Horizon 2020 research and innovation program (grant agreement no. 101003608) and conducted in the H2020 Prevent-nCoV consortium. A.S. holds an Investigator grant from the National Health and Medical Research Council of Australia (APP1173880).

PY - 2022

Y1 - 2022

KW - K18-hACE2

KW - nanoparticle vaccine

KW - SARS-CoV-2

U2 - 10.1128/jvi.00844-22

DO - 10.1128/jvi.00844-22

M3 - Letter

C2 - 35766489

AN - SCOPUS:85135228162

VL - 96

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 14

M1 - 00844-22

ER -

ID: 317092968